Home \ Neurology \ Mexidol®. Post-Stroke Rehabilitation

Mexidol®. Rehabilitation after a stroke

The brain in focus of arterial hypertension

Peculiarities of managing elderly patients

The brain is a key target organ for treatment of cerebrovascular risks

Mexidol as a geroprotector: potential and prospects

Neuroprotection in arterial hypertension and cognitive impairment

The Connection Between Vascular Diseases of the Brain and Eye: A Neurologist and Ophthalmologist's Perspective

Ischemic stroke: clinical guidelines and practical aspects

NIHSS and mRS: Gold Standards in Neuroscience

Cognitive impairment caused by arterial hypertension: from clinical guidelines to practical algorithms

The brain is a target organ for arterial hypertension: features of management of the elderly patient

Time codes:

00:00
About multidisciplinary principle in post -industry rehabilitation
01:05
Successful recovery factors after stroke
02:11
The role of neurocytoprotectors in drug rehabilitation

Vitaly Vladimirovich Kovalchuk – Doctor of Medical Sciences, Professor, Chairman of the Society of Rehabilitation Specialists of St. Petersburg, Head of the Department of Neurological Rehabilitation of the St. Petersburg State Budgetary Healthcare Institution “City Hospital No. 38 named after N.A. Semashko”

Announcement:

The consequences and complications of a stroke can be much more dangerous than the stroke itself, so it's important to provide patients with qualified and timely care. One of the key factors for successful rehabilitation after a stroke is its early initiation, including drug therapy with neurocytoprotective agents. Mexidol® after a stroke improves cerebral metabolism, microcirculation, and blood rheology, reduces platelet aggregation, and has a hypolipidemic effect.

Learn more in the video “Rehabilitation after stroke: evidence base for the drug Mexidol®.”

All videos Next video

The brain in focus of arterial hypertension

Peculiarities of managing elderly patients

The brain is a key target organ for treatment of cerebrovascular risks

Mexidol as a geroprotector: potential and prospects

Neuroprotection in arterial hypertension and cognitive impairment

The Connection Between Vascular Diseases of the Brain and Eye: A Neurologist and Ophthalmologist's Perspective

Ischemic stroke: clinical guidelines and practical aspects

NIHSS and mRS: Gold Standards in Neuroscience

Cognitive impairment caused by arterial hypertension: from clinical guidelines to practical algorithms

The brain is a target organ for arterial hypertension: features of management of the elderly patient

Time codes:

00:00
About multidisciplinary principle in post -industry rehabilitation
01:05
Successful recovery factors after stroke
02:11
The role of neurocytoprotectors in drug rehabilitation

Block of articles on this topic

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in acute and early restorations. Periods

Authors:
L.V. STAKHOVSKAYA¹, N.A. SHAMALOV¹, D.R. KHASANOVA², E.V. MELNIKOVA³, A.S. AGAFINA⁴, K.V. GOLIKOV⁵, E.I. BOGDANOV⁶, A.A. YAKUPOVA⁶, L.V. ROSHKOVSKA⁷, L.V. LUKINYKH⁸, T.M. LOKSHTANOVA⁹, I.E. Poverennova¹⁰, L.A. SCHEPANKEVICH¹¹

¹Research Institute of Cerebrovascular Pathology and Stroke, Pirogov Russian National Research Medical University, Moscow, Russia;
²Interregional Clinical and Diagnostic Center, Kazan, Russia;
³St. Petersburg City Hospital No. 26, St. Petersburg, Russia;
⁴St. Petersburg City Hospital No. 40 of the Kurortny Administrative District, St. Petersburg, Russia;
⁵St. Petersburg City Multidisciplinary Hospital No. 2, St. Petersburg, Russia;
⁶Kazan State Medical University, Kazan, Russia;
⁷St. Petersburg Nikolaevskaya Hospital, St. Petersburg, Russia;
⁸Vsevolozhsk Clinical Interdistrict Hospital, Leningrad Region, Russia.
⁹MUBZ City Clinical Hospital No. 1 named after N.I. Pirogov, Samara, Russia;
¹⁰State Budgetary Healthcare Institution Samara Regional Clinical Hospital named after V.D. Seredavin, Samara, Russia;
¹¹Federal State Budgetary Scientific Institution Research Institute of Experimental and Clinical Medicine, Novosibirsk, Russia.

The effect of therapy with the drug Mexol on the regression of neurological deficiency and a functional outcome in patients with ischemic stroke: a systematic review and meta analysis

Authors:
I.A. VOZNYUK^1,2, S.V. KOLOMETSEV^2,3, E.M. MOROZOVA¹

Features of the treatment and rehabilitation of patients who suffered Covid-19 with ischemic stroke

Authors:
G.S. RAHIMBAEVA, S.R. GAZIEVA, M.K. ATANIYAZOV, F.Kh. MURATOV, D.S. TOLIPOV, U.D. SHODIEV

Tashkent Medical Academy, Tashkent, Republic of Uzbekistan

Review of clinical recommendations for the treatment and prevention of ischemic stroke

Author:
A.I. FEDIN, K.R. BADALYAN

FSBEI in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

The effectiveness of the use of ethylmethylhydroxypyridine of succinate in the restoration treatment of patients who have undergone ischemic stroke

Authors:
M.V. ZHURAVLEVA^1,2, A.B. PROKOFIEV^1,2, V.V. ARKHIPOV¹, S.Yu. SEREBROVA^1,2, G.I. GORODETSKAYA^1,2, O.A. DEMIDOVA¹

¹Federal State Budgetary Institution "Scientific Center for Expertise of Medical Products" of the Ministry of Health of the Russian Federation, Moscow, Russia;
²Federal State Autonomous Educational Institution of Higher Education "I.M. Sechenov First Moscow State Medical University" of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com